Patterns of adjuvant chemotherapy for stage II and III colon cancer in France and Italy.

Date publication

août 2013

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BOUVIER Anne-Marie

Tous les auteurs :
Bouvier AM, Minicozzi P, Grosclaude P, Bouvier V, Faivre J, Sant M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/23428703

Résumé

BACKGROUND: European guidelines recommend adjuvant chemotherapy for stage III colon cancer but not for stage II. AIM: To determine the extent to which adjuvant chemotherapy was used in Italy and France. METHODS: A common retrospective database of 2186 colon cancers diagnosed between 2003 and 2005 was analysed according to age, stage and presenting features. RESULTS: 38.9% of patients with stage II and 64.6% with stage III received chemotherapy in Italy, 21.7% and 65.1% in France. For stage II, the association between country and chemotherapy was only significant in patients diagnosed out of emergency (ORItaly/France: 3.05 [2.12-4.37], p

Référence

Dig Liver Dis. 2013 Aug;45(8):687-91